Annovis Bio Inc. - notizie pubblicate 164 - letture 2.972
ANNOVIS BIO INC.
July 9, 2024Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ANNOVIS BIO INC.
Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS UPDRS) and Cognition after Treatment with Buntanetap Form 8 K
Annovis bio announces new data from phase iii parkinson's study highlighting improvements in unified parkinson's disease rating scale (mds-updrs) and cognition after treatment with ...
ANNOVIS BIO INC.
July 2, 2024Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
June 27, 2024Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
June 26, 2024Annovis Bio Files Patent for New Composition of Matter for Buntanetap
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
June 25, 2024Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
Initial Registration Statement for Employee Benefit Plan Form S 8
As filed with the securities and exchange commission on june 21, 2024 registration no. 333- united states securities and exchange commission washington, d.c. 20549 form s-8 r ...
ANNOVIS BIO INC.
June 18, 2024Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer annovis bio inc. published this conten ...
ANNOVIS BIO INC.
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.07 submission of matters to a vote of security holders. on june 12, 2024, annovis bio, inc. (the "company") held its 2024 annual meeting of stockholders (the " ...
ANNOVIS BIO INC.
Annovis Bio’s Buntanetap Found Safe and Effective in High Risk Alzheimer's Patients Form 8 K
Annovis bio's buntanetap found safe and effective in high-risk alzheimer's patients join our investor call for in-depth findings discussion malvern, pa., june,11 2024 (globe newswi ...
ANNOVIS BIO INC.
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast Form 8 K
Annovis bio inc. (nyse: anvs) schedules investor webcast malvern, pa. june 5, 2024 -- annovis bio inc. (nyse: anvs) ("annovis" or the "company"), a late-stage c ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti